🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #385

Cancer – Press Review (July 9, 2011) – Revue de Presse (9 juillet 2011)

#385
From: SciMedWeb
Date: Sat, 09 Jul 2011 13:16
134 lines
7077 bytes
Cancer – Press Review – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press review  (July 9, 2011) – Revue de presse (9 juillet 2011)



Experimental Drug Bests Chemo in Non-Small Cell Lung Cancer Study
Better response, progression-free survival time seen with Tarceva in
trial patients.
In U.S. News & World Report
http://health.usnews.com/health-news/family-health/cancer/articles/2011/07/05/experimental-drug-bests-chemo-in-non-small-cell-lung-cancer-study

Groundbreaking test may help personalize cancer treatment regimen
Cancer treatment in B.C. is about to get more personal — and more
comfortable — after the announcement Monday of a groundbreaking
medical project.
By Mike Raptis. In Vancouver Sun
http://www.vancouversun.com/health/Groundbreaking+test+help+personalize+cancer+treatment+regimen/5048442/story.html

Does Breast Augmentation Increase the Risk of Breast Cancer?
Many women wonder if there is a connection between breast augmentation
and breast cancer; The FDA continues to support the use of breast
implants, as extensive studies have proven their safety; The following
is evidence of how closely the medical community reviews any possible
connection between health issues and implants.
PR Newswire (press release)
http://www.prnewswire.com/news-releases/does-breast-augmentation-increase-the-risk-of-breast-cancer-125000469.html

Too many women get HPV tests: study
Doctors are testing women for human papillomavirus, or HPV -- some
strains of which have been linked to cervical cancer -- more often
than guidelines recommend, according to a new U.S. study.
By Elaine Lies. Reuters
http://www.reuters.com/article/2011/07/05/us-hpv-idUSTRE76405I20110705

Naked mole rat's genome 'blueprint' revealed
The industrious but unlovely naked mole rat is the latest creature to
have its genome sequenced by scientists. The animals are also
resistant to many diseases, particularly cancer. "I think that's the
most interesting thing about them from a biomedical perspective," said
Dr Magalhaes.
By Victoria Gill. BBC
http://www.bbc.co.uk/nature/14031978

Avastin Rejection Supported by Cancer Experts
Drug's value as metastatic breast cancer treatment still unclear, they
say. By Steven Reinberg. In U.S. News & World Report
http://health.usnews.com/health-news/managing-your-healthcare/cancer/articles/2011/07/01/avastin-rejection-supported-by-cancer-experts

Who should get a CT scan to screen for lung cancer?‎
Annual low-dose CT scans cut the death rate from lung cancer by 20
percent in heavy smokers and formerly heavy smokers.
By Jenifer GoodwinIn USA Today
http://yourlife.usatoday.com/health/medical/story/2011/07/Who-should-get-a-CT-scan-to-screen-for-lung-cancer/49019514/1

Metabolic shift may offer early cancer clue
Cancer cells are well known for their altered metabolisms, which may
help them generate the energy they need for rapid growth. Using an
emerging imaging technology, researchers reporting in the July Cell
Metabolism, a Cell Press publication, have discovered that those
metabolic shifts actually develop even before detectable tumors form.
By the same token, the studies in mice with liver cancer show that the
altered tumor metabolism shifts back before established tumors
shrink.
EurekAlert (press release)
http://www.eurekalert.org/pub_releases/2011-07/cp-msm070111.php

The Cancer Genome Atlas completes detailed ovarian cancer analysis
As part of The Cancer Genome Atlas (TCGA ) project, UNC Lineberger
researchers have contributed to the most comprehensive an integrated
view of cancer genes for any cancer type produced to date.  The UNC
team, which includes Charles Perou, PhD, professor of pathology and
laboratory medicine and genetics, Neil Hayes, MD, associate professor
of hematology/oncology, and Katie Hoadley, PhD, Research Associate,
completed the microRNA and mRNA microarray analysis that contributed
to the findings.
Media Newswire (press release)
http://media-newswire.com/release_1154492.html

La génétique des cancers du sein progresse
Il est connu depuis la dernière décennie que les mutations du gène
BRCA2 ont pour conséquence d'augmenter le risque de cancer du sein.
Les mutations sont héréditaires et l'augmentation de risque est
transmissible de la mère à la fille. Des chercheurs du Centre de
Recherche et d'Innovation en Biotechnologies de l'Université de
Copenhague (BRIC) ont récemment révélé comment le gène BRCA2
fonctionnait. Ces connaissances seront utiles pour améliorer les
traitements de cancer du sein.
Dans bulletins-electroniques.com
http://www.bulletins-electroniques.com/actualites/67176.htm

Les Français sont de plus en plus nombreux à souffrir de maladies
chroniques graves
A fin 2010, neuf millions de personnes souffraient d'une ou plusieurs
maladies chroniques graves, telles que le diabète, le cancer ou la
schizophrénie, rapporte Les Echos ce mercredi 29 juin, qui s'est
procuré un rapport transmis aux administrateurs de l'assurance-maladie
(CNAM). Depuis 2009, cette population s'est accrue de 3,9%.
Le Parisien
http://www.leparisien.fr/laparisienne/sante/les-francais-sont-de-plus-en-plus-nombreux-a-souffrir-de-maladies-chroniques-graves-29-06-2011-1513450.php







Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix – Oncowal & Wallogene (07/2011)
Technical Details
Message-ID: <c74432ac-ffc7-4ca7-9506-705b05ced292@gh5g2000vbb.googlegroups.com>
Path: arc1-ca.pugleaf.net!g2news1.google.com!postnews.google.com!gh5g2000vbb.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: f5500,bd6a8a838a9452d7,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Path: arc1-ca.pugleaf.net!g2news1.google.com!postnews.google.com!gh5g2000vbb.googlegroups.com!not-for-mail
From: SciMedWeb <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer – Press Review (July 9, 2011) – Revue de Presse (9 juillet 2011)
Date: Sat, 9 Jul 2011 06:16:40 -0700 (PDT)
Organization: http://groups.google.com
Lines: 134
Message-ID: <c74432ac-ffc7-4ca7-9506-705b05ced292@gh5g2000vbb.googlegroups.com>
NNTP-Posting-Host: 87.66.182.38
Mime-Version: 1.0
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable
X-Trace: posting.google.com 1310217401 704 127.0.0.1 (9 Jul 2011 13:16:41 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sat, 9 Jul 2011 13:16:41 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: gh5g2000vbb.googlegroups.com; posting-host=87.66.182.38; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-Google-Web-Client: true
X-Google-Header-Order: ARLUEHNKC
X-HTTP-UserAgent: Mozilla/4.0 (compatible; MSIE 8.0; Windows NT 5.1;
 Trident/4.0; .NET CLR 1.1.4322; .NET CLR 2.0.50727; InfoPath.1),gzip(gfe)